12.07.2015 Views

Guidance for Off-The-Shelf Software Use in Medical Devices

Guidance for Off-The-Shelf Software Use in Medical Devices

Guidance for Off-The-Shelf Software Use in Medical Devices

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

logic paths and complexities of OTS <strong>Software</strong> components make it important to know that designstructure or logic elsewhere <strong>in</strong> the system is not impacted. This means a full system regressiontest should be per<strong>for</strong>med. Results of these validation activities should be documented.<strong>The</strong> submission should answer the follow<strong>in</strong>g questions:• Do test reports provide objective evidence that identified OTS <strong>Software</strong> component hazardshave been addressed?• Do test reports provide objective evidence that all identified SYSTEM hazards have beenaddressed?• Has a system regression test been per<strong>for</strong>med?5.5.4 InstallationChanges <strong>in</strong> a product basel<strong>in</strong>e structure result<strong>in</strong>g from the <strong>in</strong>tegration of new OTS <strong>Software</strong>components may impact <strong>in</strong>stallation requirements. This impact can range from m<strong>in</strong>ordocumentation changes to field upgrades. <strong>The</strong> reviewer should ascerta<strong>in</strong> the impact of OTS<strong>Software</strong> component changes on fielded products.<strong>The</strong> submission should answer the follow<strong>in</strong>g question: What is the impact of new OTS <strong>Software</strong>components on fielded medical device products?For example: Do new OTS <strong>Software</strong> components correctly operate with<strong>in</strong> the specifications ofmedical devices currently fielded?5.5.5 ObsolescenceRapid technology changes, economics, and market demand are shr<strong>in</strong>k<strong>in</strong>g product life spans. Adirect consequence of these phenomena is that an OTS <strong>Software</strong> component today may not existtwo years from now. Short life spans are a particular characteristic of software because it isrelatively easy to change. Obsolescence of OTS <strong>Software</strong> components can have significantimpact on regulated products because the device manufacturer may lose the ability to properlysupport fielded products. <strong>The</strong> sponsor needs to support fielded medical device products withOTS <strong>Software</strong> components.<strong>The</strong> submission should answer the follow<strong>in</strong>g questions:• Will the old OTS <strong>Software</strong> component still be available <strong>for</strong> fielded medical devices?• Is there a retirement plan <strong>for</strong> OTS <strong>Software</strong> components to be replaced/elim<strong>in</strong>ated?• Do new OTS <strong>Software</strong> component(s) replace fielded components?5.5.6 Change control<strong>The</strong> submission must identify the product to be considered. <strong>The</strong>re<strong>for</strong>e, the product configurationprovided should specify:OTS <strong>Software</strong> <strong>Guidance</strong>, F<strong>in</strong>al page 25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!